๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ChemInform Abstract: Orbofiban: An Orally Active GPIIb/IIIa Platelet Receptor Antagonist

โœ Scribed by Nancy S. Nicholson; Norman A. Abood; Susan G. Panzer-Knodle; Leo G. Frederick; Jimmy D. Page; Anita K. Salyers; Osman D. Suleymanov; James A. Szalony; Beatrice B. Taite; Robert J. Anders

Publisher
John Wiley and Sons
Year
2010
Weight
25 KB
Volume
32
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Quantitative detection of platelet GPIIb
Quantitative detection of platelet GPIIb-IIIa receptor antagonist activity using a flow cytometric method
โœ Lisa J. Green; Philip Marder; Suzane L. Um; Joseph A. Jakubowski; Jeffry B. Lawr ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB ๐Ÿ‘ 2 views

Platelet-membrane surface receptors are important targets for pharmacologic intervention in cardiovascular disease. Among these, glycoprotein (GP) IIb-IIIa is dominant and integrally involved in platelet aggregation and thrombus formation. When activated, GPIIb-IIIa binds soluble fibrinogen (Fb) in

ChemInform Abstract: The Enantiospecific
ChemInform Abstract: The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist.
โœ L. ZHANG; J. C. CHUNG; T. D. COSTELLO; I. VALVIS; P. MA; S. KAUFFMAN; R. WARD ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons โš– 31 KB

The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist. -The crystalline compound (VI), is synthesized on a multikilogram scale in 8 steps in 37% overall yield and ยฟ99.